Novel drug effective for asthma, COPD Higher cost, longer treatment time associated with BAN for adults with wheezing, dyspnea. HealthDay News — Treating adults with wheezing or dyspnea with a ...

Nebulizers, which help deliver medication in the form of a mist that a person inhales, may be useful for those with asthma and other respiratory conditions. Portable nebulizer machines make traveling ...

The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory ...

(HealthDay News) — There are no significant clinical differences between the use of a breath-actuated nebulizer (BAN) and a handheld nebulizer (HHN) for the treatment of wheezing or dyspnea among ...

Covina, Oct. 11, 2023 (GLOBE NEWSWIRE) -- A nebulizer is a medical device used for the treatment of respiratory conditions, particularly asthma, chronic obstructive pulmonary disease (COPD), and other ...

Nebulizers, which utilize water or saline to deliver medicines directly to the lungs in a harmless vapor without heat or combustion, have been approved for decades as a safe, effective method to ...

BUFORD, Ga. , Jan. 25, 2023 (GLOBE NEWSWIRE) -- Synergy Life Science, Inc. (“Synergy”), a company pioneering the development of novel ingredients and innovative products for the consumer health and ...

ATS 2016, SAN FRANCISCO - The American Thoracic Society and Sunovion Pharmaceuticals Inc. (Sunovion) today announced the results of a survey of pulmonologists and pulmonology fellows to determine ...

“Unveiling Future Possibilities: An In-depth Exploration of the ‘Nebulizer Market Trends from 2023 to 2032’ Report” Embark on an exhilarating expedition into the realm of the booming industry, as we ...

Report Ocean presents a comprehensive research report on Nebulizer, analyzing markets in 150+ countries. With access to 1,00000+ annual reports, subject matter experts ensure accuracy. Methods like ...